市场调查报告书
商品编码
1518461
静脉输液敷料市场- 按产品(半透明、透明)、类型(胶带、非粘性敷料)、材料(聚氨酯、聚酯、棉、人造丝、硅胶、丙烯酸)、最终用途(医院和诊所、ASC) -全球预测(2024 - 2032)IV Dressing Market - By Product (Translucent, Transparent), Type (Adhesive Tapes, Non-adherent Dressings), Material (Polyurethane, Polyester, Cotton, Rayon, Silicone, Acrylic), End-use (Hospitals & Clinics, ASCs) - Global Forecast (2024 - 2032) |
在慢性病盛行率不断上升的推动下,静脉输液敷料市场在 2024 年至 2032 年期间将录得 5.5% 的复合年增长率。据 Physiopedia 称,全球约有三分之一的成年人患有多种慢性病。糖尿病、心血管疾病和癌症等慢性疾病需要长期静脉注射药物传递和输液治疗。随着全球人口老化和生活方式的变化,这些慢性疾病的发生率持续上升,推动了对有效伤口护理解决方案(包括静脉敷料)的需求。这些敷料在维持导管插入部位周围的无菌环境、预防感染和促进最佳癒合结果方面发挥着至关重要的作用。
在医疗保健支出增加和政府措施的推动下,人们越来越重视提高医疗保健的可近性和品质。这不仅将增加患者获得医疗服务的机会,还将扩大未来几年对静脉敷料的需求。
静脉注射敷料产业根据产品、类型、材料、最终用途和地区进行分类。
半透明静脉注射敷料市场将在 2032 年之前实现稳定成长,因为其透明度可以轻鬆监控插入部位,而无需移除敷料。这有助于持续观察导管插入部位是否有感染或皮肤刺激的迹象,促进早期介入并降低併发症的风险。半透明敷料还提供了针对外部污染物的屏障,同时允许医疗保健提供者在不破坏敷料的情况下评估静脉注射部位,从而提高患者的舒适度并优化临床工作流程。
到 2032 年,硅基静脉敷料市场将获得显着的吸引力,因为它具有温和的黏合特性,可以在应用或去除过程中固定敷料,而不会造成皮肤创伤。硅胶材质具有优异的透气性和皮肤贴合性,降低浸渍风险并提高患者舒适度。这些敷料也非常耐用和防水,可提供长期佩戴并防止湿气进入。硅胶静脉注射敷料特别适合皮肤敏感或需要长时间静脉注射治疗的患者,确保固定牢固并最大限度地减少更换敷料的需要,从而降低医疗成本并提高效率。
在医疗保健支出增加、对先进伤口护理解决方案的认识不断提高以及患者人数不断增加的推动下,到 2032 年,亚太地区 IV 敷料行业规模将稳步增长。旨在提高医疗保健可近性和负担能力的政府措施进一步支持该地区的市场成长。医疗设备的技术进步和创新医疗解决方案的日益采用也有助于亚太地区静脉注射敷料市场的扩张。
The IV Dressing Market will record 5.5% CAGR during 2024-2032, driven by the increasing prevalence of chronic diseases. According to Physiopedia, globally, around one-third of all adults are affected by multiple chronic conditions. Chronic conditions such as diabetes, cardiovascular diseases, and cancer require long-term intravenous therapies for medication delivery and fluid administration. As the global population ages and lifestyles change, the incidence of these chronic diseases continues to rise, driving the demand for effective wound care solutions, including IV dressings. These dressings play a crucial role in maintaining sterile environments around catheter insertion sites, preventing infections, and facilitating optimal healing outcomes.
There is a growing emphasis on improving healthcare accessibility and quality, driven by increasing healthcare expenditure and government initiatives. This will not only enhance patient access to medical care but also expand the demand for IV dressings in the coming years.
The IV dressing industry is classified based on product, type, material, end-use, and region.
The translucent IV dressings segment will witness steady growth through 2032, due to the transparency, which allows for easy monitoring of the insertion site without the need for dressing removal. This facilitates continuous observation of the catheter insertion site for signs of infection or skin irritation, promoting early intervention and reducing the risk of complications. Translucent dressings also provide a barrier against external contaminants while allowing healthcare providers to assess the IV site without disrupting the dressing, thereby improving patient comfort, and optimizing clinical workflow.
Silicone-based IV dressings segment will gain notable traction through 2032, owing to the gentle adhesive properties, which secure the dressing without causing skin trauma during application or removal. Silicone material offers excellent breathability and conformability to the skin, reducing the risk of maceration and enhancing patient comfort. These dressings are also highly durable and waterproof, providing long-term wear time and protection against moisture ingress. Silicone IV dressings are particularly suitable for patients with sensitive skin or those requiring prolonged IV therapy, ensuring secure fixation and minimizing the need for dressing changes, thus reducing healthcare costs and improving efficiency.
Asia Pacific IV dressings industry size will grow at a steady pace through 2032, driven by increasing healthcare expenditure, rising awareness about advanced wound care solutions, and expanding patient population. The government initiatives aimed at improving healthcare accessibility and affordability are further supporting market growth in the region. Technological advancements in medical devices and increasing adoption of innovative healthcare solutions are also contributing to the expansion of the IV dressing market in Asia Pacific.